Investors who purchased Zoetis Inc. securities between January 14, 2025 and May 6, 2026 must file a motion by July 27, 2026 to seek lead plaintiff appointment in a pending securities class action. The lawsuit, filed in the United States District Court for the Southern District of New York, alleges Zoetis and certain officers made false and misleading statements about the company's Companion Animal product portfolio, concealing safety concerns with Librela, competitive losses in parasiticides and dermatology, and declining veterinarian confidence. Zoetis shares fell from $151.81 before the first revelation to $87.31 following four corrective disclosures between August 2025 and May 2026. The lead plaintiff deadline applies only to those seeking to represent the class, while absent class members may still participate in any recovery without taking action by that date.
Zoetis IncLawsuit alleges false statements about product safety and competitive losses, with shares dropping significantly after corrective disclosures.